European Molecular Biology Laboratory (Heidelberg) Featured PhD Programmes
University of Huddersfield Featured PhD Programmes
University of Glasgow Featured PhD Programmes
Catalysis Hub Featured PhD Programmes
University of Sheffield Featured PhD Programmes
"cancer" AND "drugs"×
10 miles
    2. >
    3. >

cancer drugs PhD Projects, Programs & Scholarships

We have 52 cancer drugs PhD Projects, Programs & Scholarships

  • "cancer" AND "drugs" ×
  • clear all
Order by 
Showing 1 to 10 of 52
  Cardiotoxicity of cancer drugs targeting the extracellular signal-regulated kinase 1/2 (ERK1/2) cascade
University of Reading School of Biological Sciences
  Prof A Clerk
Applications accepted all year round
"Heart failure is a leading cause of morbidity and mortality worldwide. The contractile cells of the heart, cardiomyocytes, possess many protective mechanisms, allowing them to withstand pathophysiological stresses.
Details
Type/Funding
  Development of stimuli-responsive metallosupramolecular architectures for sensing and/or delivery of medicine for the treatment of solid tumours
University of Bradford Faculty of Life Sciences
  Research Group: Chemistry and Biosciences
  Dr D Petty, Dr M Najafzadeh, Dr S Pike
Applications accepted all year round
Applications are invited for a new self-funded PhD opportunity in the School of Chemistry & Biosciences at the University of Bradford.
Details
Type/Funding
  Exploration of novel approaches to anti-cancer treatment: manipulation of mutant p53
Peter MacCallum Cancer Centre Sir Peter MacCallum Department of Oncology, University of Melbourne
  Prof Y. Haupt, Dr S. Haupt
Applications accepted all year round
P53 is the most mutated gene in human cancer, affecting about half the cases of human cancer. We have recently identified novel regulators of mutant p53 using sophisticated loss of function whole genome high through put screen (image 1).
Details
Type/Funding
  Magnetic hyperthemia for cancer treatment: synthesis, biofunctionalisation of nanoparticles for thermo-chemotherapy
University College London Department of Physics and Astronomy
  Prof N T K Thanh
Application Deadline: 30 April 2019
Functional magnetic nanoparticles for cancer treatment. Supervisor. Prof Nguyen TK Thanh. [email protected]; http:/www.ntk-thanh.ac.uk.
Details
Type/Funding
  Chemical modulation of cellular redox balance for cancer treatment
University of Birmingham School of Pharmacy
  Dr I Romero-Canelon
Applications accepted all year round
Platinum complexes, cisplatin, oxaliplatin and carboplatin, are the most widely used anticancer drugs. However, these DNA-targeting treatments are a low selectivity approach with deleterious consequences and a high incidence of resistance.
Details
Type/Funding
  Targeting addiction to a breast cancer metastasis survival pathway by inhibition of RAN GTPase
University of Bradford Faculty of Life Sciences
  Research Group: Institute of Cancer Therapeutics
  Dr S Shnyder, Prof M El-Tanani, Dr S Betmouni
Applications accepted all year round
Metastatic cancer is a major global health burden. Each year, eleven million new cases of cancer are diagnosed worldwide, including 5 million cases in industrialized countries.
Details
Type/Funding
  Understanding the role of the globin cytoglobin in cancer cell drug resistance
University of Birmingham School of Biosciences
  Dr N J Hodges
Applications accepted all year round
Cytoglobin is related to haemoglobin and myoglobin but has a very poorly understood biological function. Work in our lab has shown that expression of cytoglobin in cancer cells alters mitochondrial function and affords protection from anti-cancer drugs including cisplatin.
Details
Type/Funding
  Identifying novel drug combinations to improve personalised therapy in cancer
University of Liverpool Institute of Translational Medicine
  Dr S Varadarajan
Applications accepted all year round
Failure of chemotherapeutic agents to kill cancer cells is attributed to resistance mechanisms acquired by the cancer cells, often through evasion of apoptosis.
Details
Type/Funding
  Understanding the mechanism of action of ferro-nucleobase analogues
University of Birmingham School of Biosciences
  Dr N J Hodges
Applications accepted all year round
Through collaboration with Professor Jim Tucker (School of Chemistry) we are studying the cellular effects of a novel DNA base analogues based on the organometallic compound ferrocene.
Details
Type/Funding
  (MCRC Non-Clinical) Developing cellular micromotors to improve ovarian cancer management
University of Manchester Faculty of Biology, Medicine and Health
  Dr C.K Schmidt, Prof R Edmondson, Prof D Brison, Prof S Taylor
Application Deadline: 24 March 2019
Conventional cancer chemotherapies are unspecific and elicit severe side effects. Yet, they remain the backbone of current therapies, illustrating the need for new and more specific approaches.
Details
Type/Funding
Show 10 15 30 per page
4k+

PhD Project & Programmes
Search for PhDs
PhDs by Subject
PhDs by Institution
PhDs by Country
PhDs by Email
Info for students
Postgraduate Open Days
PhD Study Guides
PhD Study Abroad
Funding Your PhD
Postgraduate Advice Forum
Postgraduate Email Updates
Info for advertisers
Advertise your PhD Project & Programmes
Provider Login
Display Advertising
Targeted Emails

FindAPhD. Copyright 2005-2019
All rights reserved.